Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith A Nutescu

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
Journal of Thrombosis and Thrombolysis|February 5, 2004
The future of anticoagulation clinicsEdith A Nutescu
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 26, 2007
ASHP therapeutic position statement on antithrombotic therapy in chronic atrial fibrillationEdith A Nutescu,
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 4, 2013
New approaches to reversing oral anticoagulant therapy. IntroductionEdith A Nutescu
Pharmacotherapy|March 26, 2010
Anticoagulation management services: entering a new eraEdith A Nutescu
Idrugs : the Investigational Drugs Journal|December 2, 2006
Drug evaluation: the directly activated Factor Xa inhibitor otamixabanEdith A Nutescu, Karen Pater
Pharmacotherapy|August 20, 2004
Evolving concepts in the treatment of venous thromboembolism: the role of factor Xa inhibitorsEdith A Nutescu, Cathy M Helgason
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 11, 2005
Current and emerging treatment options for venous thrombosis: a case discussionStuart T Haines, Edith A Nutescu
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 12, 2007
Basic terminology in obtaining reimbursement for pharmacists' cognitive servicesEdith A Nutescu, Roger S Klotz
Current Opinion in Investigational Drugs (London, England : 2000)|February 24, 2010
YM-150, a Factor Xa inhibitor for the prevention of venous thromboembolism and coronary artery diseaseAnna Markel Vaysman, Edith A Nutescu
Seminars in Thrombosis and Hemostasis|January 5, 2005
Generic warfarin: implications for clinical practice and perceptions of anticoagulation providersRachel A Bongiorno, Edith A Nutescu
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
Journal of Thrombosis and Thrombolysis|February 5, 2004
The future of anticoagulation clinicsEdith A Nutescu
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 26, 2007
ASHP therapeutic position statement on antithrombotic therapy in chronic atrial fibrillationEdith A Nutescu,
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 4, 2013
New approaches to reversing oral anticoagulant therapy. IntroductionEdith A Nutescu
Pharmacotherapy|March 26, 2010
Anticoagulation management services: entering a new eraEdith A Nutescu
Idrugs : the Investigational Drugs Journal|December 2, 2006
Drug evaluation: the directly activated Factor Xa inhibitor otamixabanEdith A Nutescu, Karen Pater
Pharmacotherapy|August 20, 2004
Evolving concepts in the treatment of venous thromboembolism: the role of factor Xa inhibitorsEdith A Nutescu, Cathy M Helgason
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 11, 2005
Current and emerging treatment options for venous thrombosis: a case discussionStuart T Haines, Edith A Nutescu
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 12, 2007
Basic terminology in obtaining reimbursement for pharmacists' cognitive servicesEdith A Nutescu, Roger S Klotz
Current Opinion in Investigational Drugs (London, England : 2000)|February 24, 2010
YM-150, a Factor Xa inhibitor for the prevention of venous thromboembolism and coronary artery diseaseAnna Markel Vaysman, Edith A Nutescu
Seminars in Thrombosis and Hemostasis|January 5, 2005
Generic warfarin: implications for clinical practice and perceptions of anticoagulation providersRachel A Bongiorno, Edith A Nutescu
Pageof 15